Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plant Research International (PRI), now integrated into Wageningen Plant Research, is a premier Dutch research organization and contract research provider specializing in plant biotechnology, genomics, and crop science. Operating as part of Wageningen University & Research, the institute bridges the gap between fundamental science and commercial application for the life sciences, pharmaceutical, and agricultural sectors. PRI is globally recognized for its expertise in 'molecular pharming,' utilizing plants as bioreactors to produce high-value biopharmaceuticals such as antibodies, vaccines, and therapeutic proteins. The organization has successfully collaborated with major industry players like Dow Chemical to engineer plants capable of producing human-like glycoproteins. Additionally, PRI leads significant efforts in metabolic engineering for natural products and the development of sustainable crops through cisgenesis and precision breeding. With world-class facilities in Wageningen, the institute remains at the forefront of translating plant science into commercial health and agricultural solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plant Research International.